Oral administration of MCC950 efficiently blocked cleaved caspase-1 generation in the brain in vivo in α-synuclein performed fibril induced-, 6-hydroxydopamine induced-PD, and MitoPark mouse model of PD (involving the knockout of Tfam gene and resulting in mitochondrial respiratory chain deficiency). This evidence concerns the gene TFAM and Parkinson disease.